Investing
Stock
Economy
Editor’s Pick

Home Investing Convertible Note and Placement

Convertible Note and Placement

by October 17, 2025

written by October 17, 2025

Carbonxt Group (CG1:AU) has announced Convertible Note and Placement

Download the PDF here.

This post appeared first on investingnews.com

0 comment

0

Facebook Twitter Pinterest Email

previous post

Editor’s Picks: Gold Price Breaks US$4,300, Silver Soars Past US$54

next post

Completes Two Pools Gold Acquisition

You may also like

Crypto Market Update: Strait of Hormuz Fears Rattle...

March 9, 2026

WALKER LANE PROVIDES UPDATE ON MANAGEMENT CEASE TRADE...

March 9, 2026

Skyharbour JV Partner Denison Mines Commences Winter Drill...

March 9, 2026

Oreterra Announces Stock Option Grant

March 9, 2026

InMed Provides Update on Pharmaceutical Development Programs –...

March 9, 2026

Brien Lundin: Gold, Silver Stock Run Just Starting,...

March 7, 2026

Peter Krauth: Silver Cycle Still Early, Big Money...

March 7, 2026

Tech Weekly: Stocks Sink as Iran War Continues,...

March 7, 2026

Top 5 Canadian Mining Stocks This Week: Adex...

March 7, 2026

Adrian Day: Gold Dips Bought Quickly, Price Run...

March 7, 2026

Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Categories

Economy (312)
Editor's Pick (514)
Investing (1,434)
Stock (250)

Editors’ Pick

Crypto Market Update: Strait of Hormuz Fears Rattle Crypto Markets
WALKER LANE PROVIDES UPDATE ON MANAGEMENT CEASE TRADE ORDER
Skyharbour JV Partner Denison Mines Commences Winter Drill Program at the Wheeler North Joint Venture in Northern Saskatchewan
Oreterra Announces Stock Option Grant
InMed Provides Update on Pharmaceutical Development Programs – Advancing Lead Drug Candidates Towards IND and Clinical Trial

About us
Contacts
Privacy Policy
Terms & Conditions

Disclaimer: fourseasongrowth.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 fourseasongrowth.com | All Rights Reserved

Investing
Stock
Economy
Editor’s Pick